price rises

Share this article: headaches continue. Bloomberg reports that the cost of fixing the website, which pretty much imploded at launch because it could not handle web traffic, is nearing $1 billion. This latest estimate is up from March's $840-million price tag, which was up from the $677 million quoted in December.

CGI Group built the website, and Bloomberg notes that the firm's financial hit amounted to forfeiting around $267,000. Accenture has been tasked with fixing the site, but has upped its price to $175 million—an $84 million bump since signing the contract in January.

Share this article:
You must be a registered member of MMM to post a comment.

Next Article in Business Briefs

Email Newsletters


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Novartis said to be stepping out of HCV

Novartis is said to have relinquished rights to an investigational hep. C treatment, signaling its exit from the therapeutic space, according to a former partner's announcement.

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.